Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma

[1]  Arun J. Sanyal,et al.  非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨 , 2015 .

[2]  F. Miller,et al.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. , 2014, Radiology.

[3]  Sheng Xu,et al.  Image fusion during vascular and nonvascular image-guided procedures. , 2013, Techniques in vascular and interventional radiology.

[4]  T. Murakami,et al.  Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  Y. Kodama,et al.  Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  W. Lau,et al.  Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Takamichi Murakami,et al.  Ultrasonography Fusion Imaging System Increases the Chance of Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Conventional Ultrasonography , 2013, Oncology.

[8]  Luca Mainardi,et al.  Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing , 2013, BMC Medical Imaging.

[9]  R. Yeung,et al.  Irreversible electroporation of a liver metastasis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Jun Kato,et al.  Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. , 2012, European journal of radiology.

[11]  T. Sugihara,et al.  Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. , 2012, European journal of radiology.

[12]  Bart Carelsen,et al.  Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study. , 2012, Journal of vascular and interventional radiology : JVIR.

[13]  S. Kumano,et al.  Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT , 2012, European Radiology.

[14]  Minshan Chen,et al.  Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. , 2012, Radiology.

[15]  U. Motosugi,et al.  Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. , 2011, Radiology.

[16]  T. Murakami,et al.  Ultrasonography, Computed Tomography and Magnetic Resonance Imaging of Hepatocellular Carcinoma: Toward Improved Treatment Decisions , 2011, Oncology.

[17]  真広 岡田.  Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging , 2011 .

[18]  Ernst Klotz,et al.  Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. , 2011, AJR. American journal of roentgenology.

[19]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[20]  Won Jae Lee,et al.  The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. , 2010, AJR. American journal of roentgenology.

[21]  C. Catalano,et al.  Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. , 2010, Radiology.

[22]  Ankur Kapoor,et al.  Navigation systems for ablation. , 2010, Journal of vascular and interventional radiology : JVIR.

[23]  Masahiro Okada,et al.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow , 2010, European Radiology.

[24]  Suk-Jin Choi,et al.  Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. , 2010, Journal of vascular and interventional radiology : JVIR.

[25]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[26]  E. Hecht,et al.  Hepatocellular carcinoma: Assessment of response to transarterial chemoembolization with image subtraction , 2010, Journal of magnetic resonance imaging : JMRI.

[27]  M V Knopp,et al.  Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. , 2009, Experimental oncology.

[28]  M. Hellmich,et al.  Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: Comparison of an extracellular and an SPIO contrast agent , 2008, Journal of magnetic resonance imaging : JMRI.

[29]  T. Murakami,et al.  Hepatocellular carcinoma treated with radio frequency ablation: An early evaluation with magnetic resonance imaging , 2008, Journal of magnetic resonance imaging : JMRI.

[30]  J. Nosher,et al.  Non-rigid Registration of the Liver in Consecutive CT Studies for Assessment of Tumor Response to Radiofrequency Ablation , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[31]  Katsunori Saigenji,et al.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. , 2007, AJR. American journal of roentgenology.

[32]  Masao Kiguchi,et al.  A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. , 2006, Academic radiology.

[33]  P. Petrow,et al.  Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. , 2002, Radiology.

[34]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[35]  Jonathan S. Lewin,et al.  Semiautomatic 3-D image registration as applied to interventional MRI liver cancer treatment , 2000, IEEE Transactions on Medical Imaging.

[36]  H. Popper.  American Association for the Study of Liver Diseases: Symposium on Toxic Hepatic Injury , 1960 .

[37]  J. Bruix,et al.  Management of HCC. , 2012, Journal of hepatology.

[38]  D. Hill,et al.  Non-rigid image registration: theory and practice. , 2004, The British journal of radiology.

[39]  A. Burroughs,et al.  Special article Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference , 2001 .